Repetitive transcranial magnetic stimulation is already FDA approved for major depressive disorder. Researchers think it could offer drug-free relief for moms.

In positive vs negative affect treatment, patients with moderate-to-severe depression or anxiety benefited more.

Earlier this week, the United States Food and Drug Administration (FDA) approved a human trial for a blueberry-sized brain ...

Anxiety is a common mental health condition characterized by excessive worry, fear or uneasiness, according to the National Institute of Mental Health. "There are several types of anxiety disorders, ...

Depression is a chemical imbalance to be managed with pills. The culprit was thought to be serotonin. The serotonin theory of ...

For decades, depression care has involved cycling through medications over 12–18 months to find one that works, often with frustrating delays and side effects. This one-size-fits-all model persists ...

McCall weighs in on lack of motivation in depression, and when it may start to come back once you're on the right treatment.

The newly approved device aims to treat depression by directly stimulating neural activity.

Sarah Tonkin, an assistant professor at the University of Arkansas, is leading a study to discover how having depression ...

A much-awaited treatment for postpartum depression, zuranolone, hit the market in December, promising an accessible and fast-acting medication for a debilitating illness. But most private health ...

The FDA’s move follows an executive order from President Donald Trump earlier this month that paved the way for more ...

About a third of people reported brain damage after electroconvulsive therapy, with many suffering memory loss, study found ...